Skip to main content
. 2024 Mar 20;8:100239. doi: 10.1016/j.jtauto.2024.100239

Fig. 1.

Fig. 1

Concentrations of anti-gp210 and anti-sp100 in 390 PBC patients (259 PBC under UDCA-naïve and 131 PBC under UDCA treatment for at least one year), and correlation of anti-gp210 concentrations with clinical parameters. A, Concentrations of anti-gp210 among 390 PBC patients; B, Concentrations of anti-sp100 among 390 PBC patients.